Vivimed Labs receives approval for 3 products from its Hyderabad site

Vivimed Labs announced today that it received approvals for 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site.

1. Bilastine tablets 20mg under brand name FLUSTIN
2. Ornidazole and Otloxacin tablets under brand name ORZOLE COMBI
3. Paracetamol 12Smg/Sml and Chlorpheniramine Maleate Syrup 2mg/Sml 100mi under brand name FEBRIL

Powered by Capital Market - Live News